The Food and Drug Administration granted full approval for the most effective drug to attack Alzheimer’s disease in decades.The follows a unanimous recommendation by neurologists at the agency last month and opens to door to broader health coverage sponsored by the federal government.An estimated 6.5 million Americans 65 and older have Alzheimer’s disease and qualify for Medicare, the government-sponsored health insurance program for seniors, which will cover all but 20 percent of the total cost of the medication.
Load More
Load More